Target intelligence / Profile preview

NLR family pyrin domain-containing protein 3 (NLRP3)

Target
NLRP3
Molecular classification
Pattern recognition receptor (PRR), Inflammasome sensor protein, Innate immune sensor, Other (NOD-like receptor family)
01

Overview

NLR family pyrin domain-containing protein 3 (NLRP3) is a cytosolic pattern recognition receptor that acts as a key sensor within the innate immune system. Upon detection of diverse danger signals—including microbial infection, cellular damage, ionic fluxes, mitochondrial dysfunction, and lysosomal rupture—NLRP3 assembles into the multiprotein NLRP3 inflammasome complex. This complex recruits the adaptor ASC and pro-caspase-1 to facilitate caspase-1 activation. Activated caspase-1 then processes pro-inflammatory cytokines interleukin 1 beta (IL-1β) and interleukin 18 (IL-18), as well as gasdermin D to induce pyroptosis—a form of inflammatory cell death. Dysregulation or hyperactivation of the NLRP3 pathway is implicated in numerous diseases characterized by chronic inflammation such as autoimmune disorders, metabolic syndrome/type 2 diabetes, neurodegeneration including Alzheimer’s disease, cardiovascular diseases, and acute inflammatory conditions like pancreatitis. Pharmacological targeting focuses on inhibiting either upstream priming events or direct assembly/activation steps within the inflammasome pathway.

Other names
NACHT, LRR and PYD domains-containing protein 3CryopyrinCIAS1NALP3PYPAF1
02

Mechanism of action

Inhibition of inflammasome assembly/activation, blockade of deubiquitination required for activation, or suppression of ATPase activity or oligomerization.

03

Biological functions

Immune responseInflammatory signalingCytokine maturation (IL-1β, IL-18)Pyroptosis induction (inflammatory cell death)
04

Disease associations

InflammationAutoimmune diseaseMetabolic disorders (e.g., type 2 diabetes)Neurodegenerative disease (e.g., Alzheimer’s disease)Cardiovascular disease
05

Safety considerations

Risk of immunosuppression/infection due to broad inhibition of innate immunity pathways when targeting NLRP3 systemically.Potential off-target effects on other inflammasomes or related immune sensors.
06

Interacting drugs

Thiolutin

3 more in the full profile.

07

Biomarkers

IL-1β levels in serum/plasmaIL-18 levelsCaspase-1 activity

Beyond the preview

Go deeper on NLR family pyrin domain-containing protein 3 (NLRP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLR family pyrin domain-containing protein 3 (NLRP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call